IMI prevention of myopia and its progression

JB Jonas, M Ang, P Cho… - … & visual science, 2021 - iovs.arvojournals.org
The prevalence of myopia has markedly increased in East and Southeast Asia, and
pathologic consequences of myopia, including myopic maculopathy and high myopia …

Myopia

PN Baird, SM Saw, C Lanca, JA Guggenheim… - Nature reviews Disease …, 2020 - nature.com
Myopia, also known as short-sightedness or near-sightedness, is a very common condition
that typically starts in childhood. Severe forms of myopia (pathologic myopia) are associated …

[HTML][HTML] Efficacy in myopia control

NA Brennan, YM Toubouti, X Cheng… - Progress in retinal and …, 2021 - Elsevier
There is rapidly expanding interest in interventions to slow myopia progression in children
and teenagers, with the intent of reducing risk of myopia-associated complications later in …

Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye …

JC Yam, Y Jiang, SM Tang, AKP Law, JJ Chan… - Ophthalmology, 2019 - Elsevier
Purpose Low-concentration atropine is an emerging therapy for myopia progression, but its
efficacy and optimal concentration remain uncertain. Our study aimed to evaluate the …

IMI–interventions for controlling myopia onset and progression report

CF Wildsoet, A Chia, P Cho… - … & visual science, 2019 - iovs.arvojournals.org
Myopia has been predicted to affect approximately 50% of the world's population based on
trending myopia prevalence figures. Critical to minimizing the associated adverse visual …

Update and guidance on management of myopia. European Society of Ophthalmology in cooperation with International Myopia Institute

J Németh, B Tapasztó, WA Aclimandos… - European Journal …, 2021 - journals.sagepub.com
The prevalence of myopia is increasing extensively worldwide. The number of people with
myopia in 2020 is predicted to be 2.6 billion globally, which is expected to rise up to 4.9 …

Three-year clinical trial of low-concentration atropine for myopia progression (LAMP) study: continued versus washout: phase 3 report

JC Yam, XJ Zhang, Y Zhang, YM Wang, SM Tang, FF Li… - Ophthalmology, 2022 - Elsevier
Purpose (1) To compare the efficacy of continued and stop** treatment for 0.05%, 0.025%,
and 0.01% atropine during the third year.(2) To evaluate the efficacy of continued treatment …

[HTML][HTML] Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis

J Huang, D Wen, Q Wang, C McAlinden, I Flitcroft… - Ophthalmology, 2016 - Elsevier
Purpose To determine the effectiveness of different interventions to slow down the
progression of myopia in children. Methods We searched MEDLINE, EMBASE, Cochrane …

Update in myopia and treatment strategy of atropine use in myopia control

PC Wu, MN Chuang, J Choi, H Chen, G Wu… - Eye, 2019 - nature.com
The prevalence of myopia is increasing globally. Complications of myopia are associated
with huge economic and social costs. It is believed that high myopia in adulthood can be …

IMI 2023 digest

P Sankaridurg, DA Berntsen… - … & Visual Science, 2023 - iovs.arvojournals.org
Myopia is a dynamic and rapidly moving field, with ongoing research providing a better
understanding of the etiology leading to novel myopia control strategies. In 2019, the …